Home LiteratureArticle Details
PMID: 18560586 Published · epublish English Journal Article Research Support, N.I.H., Intramural

MicroRNA expression and identification of putative miRNA targets in ovarian cancer.

PloS one ·Vol. 3 ·No. 6 ·2008-06-18 ·Pages e2436

Dahiya N, Sherman-Baust CA, Wang TL, Davidson B, Shih IeM, Zhang Y, Wood W, Becker KG, Morin PJ

Abstract

MicroRNAs (miRNAs) represent a class of small non-coding RNAs that control gene expression by targeting mRNAs and triggering either translation repression or RNA degradation. Emerging evidence suggests the potential involvement of altered regulation of miRNA in the pathogenesis of cancers, and these genes are thought to function as both tumor suppressors and oncogenes. Using microRNA microarrays, we identify several miRNAs aberrantly expressed in human ovarian cancer tissues and cell lines. miR-221 stands out as a highly elevated miRNA in ovarian cancer, while miR-21 and several members of the let-7 family are found downregulated. Public databases were used to reveal potential targets for the highly differentially expressed miRNAs. In order to experimentally identify transcripts whose stability may be affected by the differentially expressed miRNAs, we transfected precursor miRNAs into human cancer cell lines and used oligonucleotide microarrays to examine changes in the mRNA levels. Interestingly, there was little overlap between the predicted and the experimental targets or pathways, or between experimental targets/pathways obtained using different cell lines, highlighting the complexity of miRNA target selection. Our results identify several differentially expressed miRNAs in ovarian cancer and identify potential target transcripts that may be regulated by these miRNAs. These miRNAs and their targets may have important roles in the initiation and development of ovarian cancer.

MeSH Terms
Cell Line, Tumor Female Gene Expression Profiling Humans MicroRNAs/genetics Oligonucleotide Array Sequence Analysis Ovarian Neoplasms/genetics
Chemicals
MicroRNAs
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Dahiya Neetu
Laboratory of Cellular and Molecular Biology, Hopkins Medical Institutions, Baltimore, Maryland, United States of America.
Sherman-Baust Cheryl A
Wang Tian-Li
Davidson Ben
Shih Ie-Ming
Zhang Yongqing
Wood William
Becker Kevin G
Morin Patrice J
References (51)
51 references, click to expand
  1. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.
    Nature. 2005 Feb 17;433(7027):769-73 PMID: 15685193
  2. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation.
    Science. 2007 Mar 16;315(5818):1576-9 PMID: 17322030
  3. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.
    Cancer Cell. 2006 Mar;9(3):189-98 PMID: 16530703
  4. MicroRNA signatures in human ovarian cancer.
    Cancer Res. 2007 Sep 15;67(18):8699-707 PMID: 17875710
  5. Predicting and validating microRNA targets.
    Genome Biol. 2004;5(9):115 PMID: 15345038
  6. Clinicopathological significance of hypoxia-inducible factor-1alpha expression in human pancreatic carcinoma.
    Histopathology. 2003 Dec;43(6):550-5 PMID: 14636255
  7. Specific microRNAs are downregulated in human thyroid anaplastic carcinomas.
    Oncogene. 2007 Nov 29;26(54):7590-5 PMID: 17563749
  8. MicroRNA deregulation in human thyroid papillary carcinomas.
    Endocr Relat Cancer. 2006 Jun;13(2):497-508 PMID: 16728577
  9. A microRNA component of the p53 tumour suppressor network.
    Nature. 2007 Jun 28;447(7148):1130-4 PMID: 17554337
  10. High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.
    Clin Cancer Res. 2005 Mar 15;11(6):2215-21 PMID: 15788669
  11. Organotypic culture of human ovarian surface epithelial cells: a potential model for ovarian carcinogenesis.
    In Vitro Cell Dev Biol Anim. 1998 Sep;34(8):636-9 PMID: 9769148
  12. MicroRNA gene expression deregulation in human breast cancer.
    Cancer Res. 2005 Aug 15;65(16):7065-70 PMID: 16103053
  13. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation.
    EMBO J. 2007 Aug 8;26(15):3699-708 PMID: 17627278
  14. Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas.
    J Cell Physiol. 2007 Feb;210(2):370-7 PMID: 17111382
  15. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN.
    Cancer Res. 2008 Jan 15;68(2):425-33 PMID: 18199536
  16. Human MicroRNA targets.
    PLoS Biol. 2004 Nov;2(11):e363 PMID: 15502875
  17. Extensive modulation of a set of microRNAs in primary glioblastoma.
    Biochem Biophys Res Commun. 2005 Sep 9;334(4):1351-8 PMID: 16039986
  18. microRNAs exhibit high frequency genomic alterations in human cancer.
    Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9136-41 PMID: 16754881
  19. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
    Cancer Res. 2007 Sep 15;67(18):8433-8 PMID: 17823410
  20. MicroRNA-143 and -145 in colon cancer.
    DNA Cell Biol. 2007 May;26(5):311-20 PMID: 17504027
  21. A microRNA polycistron as a potential human oncogene.
    Nature. 2005 Jun 9;435(7043):828-33 PMID: 15944707
  22. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas.
    Cancer Cell. 2007 Sep;12(3):215-29 PMID: 17785203
  23. Reduced accumulation of specific microRNAs in colorectal neoplasia.
    Mol Cancer Res. 2003 Oct;1(12):882-91 PMID: 14573789
  24. RAS is regulated by the let-7 microRNA family.
    Cell. 2005 Mar 11;120(5):635-47 PMID: 15766527
  25. A microRNA expression signature of human solid tumors defines cancer gene targets.
    Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61 PMID: 16461460
  26. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis.
    Circ Res. 2007 Jul 6;101(1):59-68 PMID: 17540974
  27. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
    Cancer Res. 2004 Jun 1;64(11):3753-6 PMID: 15172979
  28. Identification of novel genes coding for small expressed RNAs.
    Science. 2001 Oct 26;294(5543):853-8 PMID: 11679670
  29. miR-21-mediated tumor growth.
    Oncogene. 2007 Apr 26;26(19):2799-803 PMID: 17072344
  30. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.
    N Engl J Med. 2005 Oct 27;353(17):1793-801 PMID: 16251535
  31. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.
    Gastroenterology. 2007 Aug;133(2):647-58 PMID: 17681183
  32. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans.
    Science. 2001 Oct 26;294(5543):858-62 PMID: 11679671
  33. Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies.
    Clin Cancer Res. 2003 Oct 15;9(13):4811-8 PMID: 14581352
  34. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis.
    Nucleic Acids Res. 2005 Mar 01;33(4):1290-7 PMID: 15741182
  35. The colorectal microRNAome.
    Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3687-92 PMID: 16505370
  36. MicroRNA expression profiling in prostate cancer.
    Cancer Res. 2007 Jul 1;67(13):6130-5 PMID: 17616669
  37. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells.
    J Biol Chem. 2008 Jan 11;283(2):1026-33 PMID: 17991735
  38. MicroRNA expression profiles classify human cancers.
    Nature. 2005 Jun 9;435(7043):834-8 PMID: 15944708
  39. Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells.
    Cancer Res. 2004 Mar 1;64(5):1757-64 PMID: 14996737
  40. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
    Cancer Res. 2005 Nov 1;65(21):9628-32 PMID: 16266980
  41. Switching from repression to activation: microRNAs can up-regulate translation.
    Science. 2007 Dec 21;318(5858):1931-4 PMID: 18048652
  42. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis.
    JAMA. 2007 May 2;297(17):1901-8 PMID: 17473300
  43. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior.
    J Clin Oncol. 2006 Oct 10;24(29):4677-84 PMID: 16966691
  44. MicroRNAs: genomics, biogenesis, mechanism, and function.
    Cell. 2004 Jan 23;116(2):281-97 PMID: 14744438
  45. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis.
    Nature. 1998 Jul 30;394(6692):485-90 PMID: 9697772
  46. MicroRNA signatures in human cancers.
    Nat Rev Cancer. 2006 Nov;6(11):857-66 PMID: 17060945
  47. MicroRNAs modulate the angiogenic properties of HUVECs.
    Blood. 2006 Nov 1;108(9):3068-71 PMID: 16849646
  48. miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer.
    Cancer Biol Ther. 2008 Feb;7(2):255-64 PMID: 18059191
  49. MicroRNA expression profiles in head and neck cancer cell lines.
    Biochem Biophys Res Commun. 2007 Jun 22;358(1):12-7 PMID: 17475218
  50. Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer.
    Carcinogenesis. 1995 Apr;16(4):707-11 PMID: 7728947
  51. Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas.
    Clin Cancer Res. 2003 Jul;9(7):2567-75 PMID: 12855632
Article Info
Journal
PloS one
Abbr.
PLoS One
ISSN
1932-6203
Published
2008-06-18
Epub
2008-00-18
Pages
e2436
Language
English
Region
United States
NLM ID
101285081
PMCID
PMC2410296
Subset
IM
Grants
Intramural NIH HHS · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com